• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOGASTRIC SOLUTIONS, INC ESOPHYX Z+; ODE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOGASTRIC SOLUTIONS, INC ESOPHYX Z+; ODE Back to Search Results
Model Number R2007
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Fever (1858); Perforation of Esophagus (2399)
Event Date 06/29/2021
Event Type  Injury  
Manufacturer Narrative
Endogastric solutions initially became aware of a potential adverse event on 22 march 2022.After multiple documented attempts to obtain information, it was not until 18 may 2022 when this adverse event was confirmed by the physician.The physician is not alleging a product malfunction caused or contributed to the patient adverse event and the product was not returned to endogastric solutions (egs) for evaluation.The device was discarded at the medical facility by the hospital staff and is unavailable for return to egs.The physician is alleging the tif procedure may have caused/contributed to the reported esophageal leak as well as the reported uncontrollable retching and vomiting after the procedure.Based on the available information received by egs, the cause of the reported incident could not be conclusively determined.
 
Event Description
The physician stated a patient who underwent a successfully completed tif procedure experienced uncontrollable retching and vomiting in the recovery room post procedure.The patient was readmitted three days post tif after experiencing fever and chest pain where they underwent a ct scan as well as a esophogram.An esophageal stent was placed to treat the distal esophageal leak six days post tif.The patient was admitted again twenty-nine days post tif to treat a dislodged esophageal stent.The patient is reportedly doing well as of (b)(6) 2022.
 
Manufacturer Narrative
Updating health effect clinical code (e) to only include: 2399, 1776, and 1858.Updating health effect impact code (f) to only include: 4614, 4621, 4641, and 4607.Updating type of investigation (b) to only include: 4112, 4109, 4110, 4115, and 4111.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESOPHYX Z+
Type of Device
ODE
Manufacturer (Section D)
ENDOGASTRIC SOLUTIONS, INC
18109 ne 76th street
suite 100
redmond WA 98052
Manufacturer (Section G)
ENDOGASTRIC SOLUTIONS, INC
18109 ne 76th st
suite 100
redmond WA 98052
Manufacturer Contact
vishnu venkatesan
18109 ne 76th st
suite 100
redmond, WA 98052
4253079248
MDR Report Key14500136
MDR Text Key294780578
Report Number3005473391-2022-00164
Device Sequence Number1
Product Code ODE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K172811
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberR2007
Device Catalogue NumberR2007
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/18/2022
Initial Date FDA Received05/25/2022
Supplement Dates Manufacturer Received05/18/2022
Supplement Dates FDA Received03/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age32 YR
Patient SexFemale
Patient Weight51 KG
-
-